Xian Xice Testing Technology Co. Ltd. A

A-shares plunged over the past week. Harbin Pharmaceutical became the top-performing stock with a weekly gain of 58.16%, while Meixin Technology led the decline with a drop of 41.12%. Harbin Pharmaceutical disclosed on July 9 that its attributable net profit for the first half of 2026 is expected to increase by 46.40% to 68.36%, and that 118 of its product specifications have been included in the new edition of the National Essential Medicines List. The stock hit consecutive daily limit-up moves, but the limit was broken on July 17, closing up 7.89%. Meixin Technology saw profit-taking after its share price hit a record high, plunging over 41% for the week. Despite revenue growth in the first quarter, net profit fell 33.32% year-on-year. Coupled with a broad sell-off in tech stocks, the share price underwent a sharp correction. All ten stocks on this week's bear list posted weekly declines exceeding 39%, mostly due to concentrated capital outflows after prior highs.